BICX
BioCorRx Inc.Company Information
- Company Name
- BioCorRx Inc.
- CIK
- CIK0001443863
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- BICX: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8093
- SIC Description
- Services-Specialty Outpatient Facilities, NEC
- Ticker
- BICX
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-01-16
- Last sale
- —
- Shares purchased (TTM)
- 343,818
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2019-06-30
- Institutional shares owned
- 1,000
- Shares outstanding
- 3,057,848
- Ownership
- 0.03%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 38.16%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets | ||||||||||||||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Grants Receivable | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Grants Receivable Current | 0 | 0 | 0 | 1 | 0 | - | 0 | - | - | - | - | - | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | - | - | 1 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Other Assets | ||||||||||||||||||
| Other Assets | 1 | 1 | 1 | 6 | 6 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Capitalized Software Development Costs For Software Sold To Customers | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Other Intangible Assets Net | 1 | 1 | 1 | 3 | 3 | 3 | 0 | - | - | - | - | - | ||||||
| Goodwill | 1 | 1 | 1 | 3 | 3 | 3 | 0 | - | - | - | - | - | ||||||
| Deposit Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | - | ||||||
| Assets | 2 | 2 | 2 | 8 | 7 | 7 | 0 | 1 | 0 | 0 | 0 | 1 | ||||||
| Development Costs Cumulative | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 7 | 7 | 6 | 12 | 12 | 11 | 6 | 6 | 5 | 5 | 5 | 4 | ||||||
| Deferred Revenue Current | 0 | - | 0 | 0 | 0 | - | 0 | - | - | - | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 9 | 9 | 8 | 15 | 15 | 13 | 8 | 8 | 7 | 7 | 6 | 6 | ||||||
| Derivative Liabilities | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable Current | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Other Long Term Debt Noncurrent | - | - | - | 0 | - | - | - | - | - | - | - | - | ||||||
Economic Injury Disaster Loan Long Term | ||||||||||||||||||
| Construction Loan Noncurrent | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Accrued Royalties Current And Noncurrent | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | - | ||||||
| Contractual Obligation | 5 | 5 | 5 | - | - | - | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Deferred Revenue Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 14 | 14 | 14 | 20 | 20 | 19 | 13 | 13 | 12 | 11 | 10 | 10 | ||||||
Commitments And Contingencies Disclosure | ||||||||||||||||||
| Preferred Stock Value | - | - | - | 0 | - | - | - | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Subscriptions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 76 | 76 | 75 | 74 | 73 | 72 | 71 | 70 | 69 | 68 | 68 | 68 | ||||||
| Retained Earnings Accumulated Deficit | -89 | -87 | -87 | -87 | -85 | -84 | -83 | -82 | -81 | -79 | -78 | -77 | ||||||
| Stockholders Equity | -12 | -11 | -11 | -13 | -13 | -12 | -12 | -12 | -11 | -11 | -10 | -9 | ||||||
| Minority Interest | -0 | -0 | -0 | 1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 2 | 2 | 2 | 8 | 7 | 7 | 0 | 1 | 0 | 0 | 0 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | 0.00 | - | - | - | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.31 | 0.00 | 0.75 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock No Par Value | - | - | - | - | - | - | - | 0 | 0 | 0 | - | - | ||||||
| Common Stock Shares Authorized | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | ||||||
| Common Stock Shares Issued | 30 | 29 | 24 | 20 | 17 | 17 | 13 | 11 | 10 | 9 | 9 | 9 | ||||||
| Shares Outstanding | 30 | 29 | 24 | 11 | 17 | 17 | 13 | 11 | 10 | 9 | 9 | 9 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBioCorRx Inc. (BICX) — SEC Financial Statements & Analysis
BioCorRx Inc. (BICX) is a services-specialty outpatient facilities, nec company. BioCorRx Inc. trades on OTC as: BICX. BioCorRx Inc. (BICX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, BioCorRx Inc. carries a market cap of $10.09M, a P/E ratio of -3.25x, a P/B ratio of -0.81x, a P/S ratio of 12.82x, an enterprise value of $11.34M, and an EV/EBITDA multiple of -2.30x. On profitability, it posts a gross margin of 91.04%, an operating margin of -623.09%, a net margin of -394.65%, a Return on Equity (ROE) of 24.36%, and a Return on Assets (ROA) of -72.29%. Per share, it reports EPS of $-0.10, diluted EPS of $-0.11, free cash flow per share of $-0.08, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 95.78% year-over-year, net income growth of -36.17% year-over-year, and EPS growth of -63.40% year-over-year. On the balance sheet, it maintains a current ratio of 0.07x, a quick ratio of 0.02x, working capital of $-8.23M, a debt-to-equity ratio of -1.15x, a debt ratio of 7.54, an interest coverage ratio of -30.49x, free cash flow of $-2.36M (TTM), and net debt of $1.25M. Figures sourced from SEC EDGAR.
- Market Cap
- $10.09M
- P/E TTM
- -3.25x
- EPS TTM
- $-0.10
- P/B TTM
- -0.81x
- ROE TTM
- 24.36%
- ROA TTM
- -72.29%
- Debt To Equity
- -1.15x
- Free Cash Flow TTM
- $-2.36M
- Net Revenue TTM Growth 1Y
- 95.78%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BioCorRx Inc. in?
BioCorRx Inc. (BICX) operates in the Services-Specialty Outpatient Facilities, NEC industry.
What exchange does BICX trade on?
BioCorRx Inc. (BICX) trades on the OTC.
When was BioCorRx Inc. (BICX)'s most recent SEC filing?
BioCorRx Inc. (BICX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is BICX's market cap?
BioCorRx Inc. (BICX) has a market capitalization of $10.09M as of 2026-06-30.
What is BICX's EPS (earnings per share)?
BioCorRx Inc. (BICX)'s trailing twelve month EPS is $-0.10 as of 2026-06-30.
What is BICX's ROE (return on equity)?
BioCorRx Inc. (BICX)'s trailing twelve month Return on Equity (ROE) is 24.36% as of 2026-06-30.
What is BICX's ROA (return on assets)?
BioCorRx Inc. (BICX)'s trailing twelve month Return on Assets (ROA) is -72.29% as of 2026-06-30.
What is BICX's EV/EBITDA?
BioCorRx Inc. (BICX)'s trailing twelve month EV/EBITDA is -2.30x as of 2026-06-30.